MRNA

ModernaD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

MRNA vs peer average

38/100

MRNA vs. peer average (D vs. C)

Grade spread

B 3 · C 4 · D 2 · F 2

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

ASND is the first available peer comparator.

Ascendis is a closer market-cap biopharma comp with a rare-disease commercialization and pipeline-conversion story, highlighting that Moderna still needs cleaner proof that new launches can diversify revenue beyond COVID.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerASNDAscendis A/S

MRNA

Moderna

ASND

Ascendis A/S

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs ASND

MRNA / ASND

Grade Position

Below peers

MRNA vs. peer average (D vs. C)

38/100

Momentum

MRNA

Value

ASND

Sentiment

MRNA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs MRNA

ASND

20/100

IONS

60/100

-1

MDGL

20/100

INSM

Insmed Inc Common

80/100

-2

INCY

Incyte Corp Common

80/100

-2

ASND is the first peer returned for this comparison set.